Three items of pandemic news you may have missed recently: Canada is struggling; J&J is ordered to take over Emergent’s factory; and the mRNA vaccines appear safe and effective in pregnant women. Plus news briefs and a frippery. mRNA shots … Continue reading →
Three items of pandemic news you may have missed recently: Moderna can pack more doses per vial; Emergent’s big mistake; and news on vaccines for kids as young as 12. Plus news briefs and a pair of fripperies. Pfizer is … Continue reading →
Herewith three items of pandemic news you may have missed recently: The latest installment in the ongoing AstraZeneca saga; how the immunosuppressed respond to mRNA vaccination; and Minnesota’s opening up of eligibility for shots. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed: Vitamin D levels vs. infection probability in Black people; variant viruses infecting animals; and the roller coaster that is AstraZeneca’s Phase III results announcement. Plus news briefs and a frippery. … Continue reading →
Three items of pandemic news you may have missed recently: Kids and Covid-19; enhanced lethality of the B.1.1.7 variant; and more on the pause in AstraZeneca shots as Europe investigates a rare condition. Plus news briefs and a frippery. AstraZeneca … Continue reading →
Herewith three items of pandemic news you may have missed recently: One instance in Oregon of a scary variant; quantifying the variants’ immune escape; and the new CDC guidelines. Plus news briefs and a frippery. A year Before we dive … Continue reading →
Herewith three items of pandemic news you may have missed recently: Controlling the message on vaccines of different efficacy; Johnson & Johnson’s day in the spotlight; and media jumping the gun on viral variant stories. Plus news briefs and a … Continue reading →
Herewith three items of pandemic news you may have missed recently: A caution for those scheduling mammograms around the time of vaccination; sterilizing immunity from vaccines; and peptides for prevention and treatment. Plus news briefs and a frippery. Peptides Dr. … Continue reading →
Herewith three items of pandemic news you may have missed: Concern about reinfections in Israel; evidence that the B.1.1.7 virus variant causes more serious disease; and an introduction to the newest variant from California. Plus news briefs and a frippery. … Continue reading →
Three items of pandemic news you may have missed recently: FDA signals a streamlined approval path for vaccine updates; South Africa halts AstraZeneca distribution; and Moderna demonstrates its shot’s efficacy against viral variants. Plus news briefs and a frippery. Moderna’s … Continue reading →
Herewith three items of pandemic news you may have missed recently: A trial of mixed shots begins in the UK; a sobering tale of a variant’s spread; and J&J applies for an EUA. Plus news briefs and a frippery. Johnson … Continue reading →
Herewith three items of pandemic news you may have missed recently: Cautionary lessons from Brazil’s second wave in Manaus; CureVac’s manufacturing partnership with Bayer; and long Covid’s entanglement with autoantibodies. Plus news briefs and a frippery. Autoantibodies and long Covid … Continue reading →
Herewith three items of pandemic news you may have missed recently: The South African variant shows up in the US; pharma giants are helping each other out; and Novavax reads out preliminary results. Plus news briefs and a frippery. Novavax … Continue reading →
Herewith three items of pandemic news you may have missed recently: Pfizer gets permission to ship fewer vials; how non-pharmaceutical interventions have varied over the course of the pandemic; and how vaccines are coping with the new virus variants. Plus … Continue reading →
Herewith three items of pandemic news you may have missed recently: More on virus variants; Novavax’s Phase III study is leaking volunteers; and vaccine hesitancy in the Black population. Plus news briefs and a frippery. Black vaccine hesitancy For all … Continue reading →
